Skip to main content

Market Overview

Germany's Merck Invests In French Facility For Single Use Products


Germany’s Merck KGaA (OTCMKT: MKGAF) will invest €25 million in its Molsheim, France facility to make disposable materials for bioreactors, an essential material required for COVID-19 vaccine manufacturing.

  • The new site will see the creation of 350 jobs, along with 1,700 square meters of cleanrooms. 
  • The new unit will produce Mobius single-use assemblies. It is planned to be operational by the end of this year.
  • Molsheim will be the first site in Europe where the Life Science business sector manufactures the product. Further production sites are located in Danvers, Massachusetts, and Wuxi, China.
  • Price Action: MKAGF shares are trading 1% lower at $162.32 in market trading hours on the last check Wednesday.

Related Articles (MKGAF + MKKGY)

View Comments and Join the Discussion!

Posted-In: Covid-19Biotech News Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at